Shield Therapeutics plc
STX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£7 | -£9 | -£12 | -£17 |
| Dep. & Amort. | £1 | £1 | £0 | £0 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | £2 | £5 | £7 | £2 |
| Other Non-Cash | £1 | -£0 | £1 | £1 |
| Operating Cash Flow | -£4 | -£4 | -£3 | -£14 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£1 | -£1 | -£1 | -£1 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £1 | -£1 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £0 | £0 | £0 |
| Investing Cash Flow | -£1 | -£0 | -£2 | -£1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £4 | £0 | £11 |
| Stock Issued | £0 | -£0 | £0 | £21 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £8 | -£0 | -£0 | -£17 |
| Financing Cash Flow | £8 | £4 | -£0 | £16 |
| Forex Effect | £0 | -£1 | £0 | -£1 |
| Net Chg. in Cash | £2 | -£1 | -£5 | £0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £6 | £6 | £11 | £11 |
| End Cash | £8 | £6 | £6 | £11 |
| Free Cash Flow | -£4 | -£4 | -£4 | -£15 |